Reduction of Smoking in Cardiac Disease Patients
Status: | Completed |
---|---|
Conditions: | Peripheral Vascular Disease, Smoking Cessation, Tobacco Consumers |
Therapuetic Areas: | Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/11/2017 |
Start Date: | January 2001 |
End Date: | December 2005 |
Harm Reduction Treatment for Smokers With Cardiovascular Disease {Reduction of Smoking in Cardiovascular Disease Patients (ROSCAP)}
This study evaluates the effect of smoking reduction vs usual care (quitting advice only)
for individuals with peripheral arterial disease who smoke.
for individuals with peripheral arterial disease who smoke.
This study randomly assigns smokers who do not have a quit date set to either a smoking
reduction grop or usual care group. The smoking reduction group receives behavioral
counseling on smoking reduction and nicotine patch and/or gum to reduce the number of
cigarettes smoked per day by at least 50%. The usual care group is given brief advice to
quit smoking and referral to local cessation services. To be included in the study,
participants must have peripheral arterial disease (defined as ankle Brachial Index equal to
or less than 0.85 or history of prior revascularization) and they must be daily smokers
(defined as at least 1 cigarette, cigar, or tobacco pipe daily). Participants complete
questionnaires that measure mood, functional ability, smoking history, and motivation to
quit smoking. Participants will be followed in this study for up to 24 months.
reduction grop or usual care group. The smoking reduction group receives behavioral
counseling on smoking reduction and nicotine patch and/or gum to reduce the number of
cigarettes smoked per day by at least 50%. The usual care group is given brief advice to
quit smoking and referral to local cessation services. To be included in the study,
participants must have peripheral arterial disease (defined as ankle Brachial Index equal to
or less than 0.85 or history of prior revascularization) and they must be daily smokers
(defined as at least 1 cigarette, cigar, or tobacco pipe daily). Participants complete
questionnaires that measure mood, functional ability, smoking history, and motivation to
quit smoking. Participants will be followed in this study for up to 24 months.
Inclusion Criteria:
- To be included in the study, participants must have peripheral arterial disease
(defined as ankle Brachial Index equal to or less than 0.85 or history of prior
revascularization) and they must be daily smokers (defined as at least 1 cigarette,
cigar, or tobacco pipe daily).
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials